日日噜夜夜草|一级黄色录像高清版|调教白富美加勒比久久|亚洲欧洲精品婷婷|日韩综合无码色色|日韩精品一区妖精视频|亚洲无码中文字幕hd|99亚洲思思丝袜|手机看片国产精品大胆亚洲|成人无码视频一区二区在线播放

更新于 5月29日

GMP Alliance Lead

7.5-12萬(wàn)
  • 上海靜安區(qū)
  • 5-10年
  • 本科
  • 全職
  • 招1人

雇員點(diǎn)評(píng)標(biāo)簽

  • 同事很nice
  • 團(tuán)隊(duì)執(zhí)行強(qiáng)
  • 工作環(huán)境好
  • 人際關(guān)系好
  • 氛圍活躍
  • 實(shí)力大公司

職位描述

藥企
ROLE SUMMARY: This role reports directly to BU GM. The GMP Alliance Lead will be accountable for delivering the General Medicine Portfolio P&L in Pfizer China, leading General Medicine Portfolio strategy, and fostering business innovation to successfully achieve business outcome including but no limited to revenue, market shar, productivity and IBT objectives, maximize business growth and optimizing business sustainability. This role will work closely with and manage 3rd party/partners to achieve business outcomes, establishing strategic partnerships and ensuring robust alliance management and strategic execution in core therapeutic areas and overseeing deal implementations to enhance the competitive advantages of Pfizer's General Medicine Portfolio. Develop and promote collaborative innovation projects to explore the brand value of Pfizer products and increase the accessibility of patients. ROLE RESPONSIBILITIES: ● Accountable for delivering the General Medicine Portfolio P&L in Pfizer China; ● Develop portfolio and partner strategies for GMP products of Pfizer China to engage well-matched strategic partners with strong capability & cooperation willingness, and well-orchestrated cross-functional execution excellence; ● Establishing strategic partnerships with 3rd party/partners to foster business innovation; ● Build-up systematic performance review mechanism and dashboard tracking to achieve business goals( TTD/TTH/IBT) with well-defined 3M strategy; ● Achieve business target of established products through cooperating with qualified 3rd party/partners, governing their GTM model via effective collaboration /management process; ● Lead smooth transition and deal implementation for each CSO deal or cooperation program; ● Support managing and ensure the supply of established products via cooperating with global and local S&OP team, local DCM team; ● Cooperate with relevant function teams to build SOP of CSO/license-out model, covering internal evaluation/partner screening/deal negotiation and transition/deal execution /monitoring /termination at company level; build response plan for possible risk; ● Cooperate with Compliance/Legal/Audit team to build high standard monitoring model for collaboration with partners; ● Build strong network/relationship with potential external partners and stakeholders, help improve capability of partners; ● Build established portfolio function team with strong talents and define & develop capabilities of commercial excellence QUALIFICATIONS AND REQUIREMENTS: ● Bachelor’s degree in Business, Marketing, Pharmacy, or a related field, MBA is perfectible. ● Proven experience in portfolio management, strategic planning, and cross-functional team leadership. ● Able to interact, partner, and provide thought leadership for key stakeholders with comfort and ease. ● Strong business acumen, strong understanding of the China pharmaceutical industry and market dynamics. ● Excellent communication, negotiation, leadership, and strong interpersonal and influencing capabilities ● Ability to manage complex projects and drive them to successful completion. ● Knowledge of compliance and regulatory requirements in the pharmaceutical industry. ● Excellent oral and written communications capabilities and presentation and facilitation skills Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates. Mkt & Sales/Commercial Bus #LI-PFE

工作地點(diǎn)

上海靜安區(qū)中信泰富廣場(chǎng)

職位發(fā)布者

劉一飛/人事經(jīng)理

當(dāng)前在線(xiàn)
立即溝通
公司Logo輝瑞投資有限公司公司標(biāo)簽
輝瑞公司(Pfizer Inc.)創(chuàng)建于1849年,總部位于美國(guó)紐約,是一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。輝瑞的使命是“為患者帶來(lái)改變其生活的突破創(chuàng)新”。在輝瑞,我們通過(guò)科學(xué)和全球資源為人們提供治療方案,以延長(zhǎng)其生命,顯著改善其生活。在醫(yī)療衛(wèi)生產(chǎn)品的探索、研發(fā)和生產(chǎn)過(guò)程中,輝瑞始終致力于奉行嚴(yán)格的質(zhì)量、安全和價(jià)值標(biāo)準(zhǔn)。我們?cè)谌虻漠a(chǎn)品組合包括創(chuàng)新藥品和疫苗。每天,輝瑞在發(fā)達(dá)和新興市場(chǎng)的員工都在推進(jìn)人類(lèi)健康,推動(dòng)疾病的預(yù)防、治療和治愈,以應(yīng)對(duì)挑戰(zhàn)我們這個(gè)時(shí)代的頑疾。輝瑞還與醫(yī)療衛(wèi)生服務(wù)方、政府和社區(qū)合作,支持并促進(jìn)世界各地的人們能夠獲得更為可靠和可承付的醫(yī)療衛(wèi)生服務(wù)。這與輝瑞作為一家全球卓越的創(chuàng)新生物制藥公司的責(zé)任是一致的。170余年來(lái),輝瑞一直致力于為所有依賴(lài)我們的人帶來(lái)改變。輝瑞于1989年進(jìn)入中國(guó)市場(chǎng)。扎根中國(guó)30余年,輝瑞已成為在華主要的外資制藥公司之一。2021年是輝瑞新征程的開(kāi)始。迄今已有170余年歷史的輝瑞正在邁入全新時(shí)代,成為一家以科學(xué)為基礎(chǔ)的、創(chuàng)新的、以患者為先的生物制藥公司。目前輝瑞在中國(guó)業(yè)務(wù)覆蓋全國(guó)300余個(gè)城市,累計(jì)投資超過(guò)15億美元,并設(shè)立了1家先進(jìn)的生產(chǎn)設(shè)施,2個(gè)研發(fā)中心(分別位于上海張江高科技園區(qū)和武漢光谷),在華有近7,000名員工分布于業(yè)務(wù)、研發(fā)和生產(chǎn)等領(lǐng)域。輝瑞在華上市了五大領(lǐng)域的高品質(zhì)創(chuàng)新產(chǎn)品,包括腫瘤、疫苗、抗感染、炎癥與免疫、罕見(jiàn)病等多個(gè)領(lǐng)域的處方藥和疫苗,強(qiáng)大完善的產(chǎn)品線(xiàn)旨在滿(mǎn)足生命各階段的健康需求。
公司主頁(yè)